BioArctic AB (CHIX:BIOABS) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BIOABS BioArctic AB CHIX:BIOABS
74 GF Score
Price kr324.30
GF Value kr466.63
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is BioArctic AB Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:BIOABS
74GF Score
BioArctic AB CHIX:BIOABS
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (CHIX:BIOABS) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of kr324.30 is trading 30.5% below its estimated GF Value™ of kr466.63. GuruFocus considers BioArctic AB to be Possible Value Trap.

Key valuation signals for CHIX:BIOABS:

  • Short Ratio:
  • GF Value™: kr466.63 vs. price of kr324.30 (30.5% below fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the CHIX:BIOABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
74GF Score

Get the complete analysis for CHIX:BIOABS

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr324.30
Price
kr466.63
GF Value